Stock APO ACASTI PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Acasti Pharma Inc Toronto S.E.

Equities

APO

CA00430K1057

End-of-day quote Toronto S.E.
Other stock markets
- CAD - Intraday chart for Acasti Pharma Inc
06-21 Acasti Pharma Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
05-28 Acasti Pharma Inc. to Attend BIO International Convention 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
AQ
Acasti Pharma Inc. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Acasti Pharma to Attend BIO International Convention 2024
AQ
Acasti Pharma Inc. to Attend BIO International Convention 2024
CI
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
AQ
Acasti: Fiscal Q3 Earnings Snapshot
AQ
Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target
MT
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
AQ
Acasti Pharma Inc. Announces Poster Detailing Its GTX-104 STRIVE-ON Trial
CI
Acasti Pharma Inc. Approves Appointment of Robert J. Delaversano, as Principal Financial Officer and Principal Accounting Officer
CI
Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024
AQ
Brain Hemorrhage Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)
AQ
Acasti: Fiscal Q2 Earnings Snapshot
AQ
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
AQ
Acasti Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Aker BioMarine Gains Krill Assets from Acasti Pharma in $3.1 Million Settlement Deal
MT
Aker BioMarine acquires patents, equipment, and scientific data from Acasti Pharma Inc
AQ
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
AQ
Acasti Pharma Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACST Stock
  4. APO Stock
  5. News Acasti Pharma Inc